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Introduction {#phy214040-sec-0001}
============

Erythrocyte or red‐blood‐cell (RBC) *n*−3 fatty‐acid status is related to health outcomes, including cardiovascular disease, myocardial infarction, arrhythmias, and sudden death (Bucher et al. [2002](#phy214040-bib-0005){ref-type="ref"}). Fish consumers have less cardiovascular disease (Huang et al. [2011](#phy214040-bib-0015){ref-type="ref"}; InterAct Consortium, [2011](#phy214040-bib-0016){ref-type="ref"}). The two most important omega‐3 (*n*−3) polyunsaturated fatty acids are eicosapentaenoic acid (EPA, C20:5 *n*−3) and docosahexanoic acid (DHA, C22:6 *n*−3). DHA‐rich fish oil supplementation favorably modulates body composition in type‐2 diabetic and obese patients (Mansoori et al. [2015](#phy214040-bib-0023){ref-type="ref"}). *n*−3 fatty‐acid affect diets RBC membrane fatty acid composition (Popp‐Snijders et al. [1986](#phy214040-bib-0029){ref-type="ref"}). For example, a daily fish‐oil concentrate supplement, providing 3 g of omega‐3 fatty acids, increases incorporation of C20:5 omega 3 into RBCs, at the expense of C18:2 omega 6 fatty acids, but total unsaturation of phospholipids is increased (Cartwright et al. [1985](#phy214040-bib-0007){ref-type="ref"}). The *n*−6 fatty acid, linoleic acid (LA), and the *n*−3 fatty acids, linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) collectively protect against coronary heart disease (Wijendran and Hayes [2004](#phy214040-bib-0039){ref-type="ref"}). The *n*−3 fatty acids, especially EPA and DHA, are potent anti‐arrhythmic agents (von Schacky [2004](#phy214040-bib-0030){ref-type="ref"}; Wijendran and Hayes [2004](#phy214040-bib-0039){ref-type="ref"}). Patients with low RBC *n*−3 and *n*−6 fatty acids, palmitoleic acid, and stearic acid status have an increased risk of acute coronary syndromes (Shearer et al. [2009](#phy214040-bib-0034){ref-type="ref"}). EPA and DHA improve endothelial function, lower blood pressure, and favorably act on platelets (Wijendran and Hayes [2004](#phy214040-bib-0039){ref-type="ref"}). A low omega‐3 index (the percentage of EPA+DHA in red‐cell lipids) independently increases cardiovascular‐disease risk and mortality (von Schacky [2015](#phy214040-bib-0031){ref-type="ref"}; Kleber et al. [2016a](#phy214040-bib-0018){ref-type="ref"},[2016b](#phy214040-bib-0019){ref-type="ref"}; Thuppal et al. [2017](#phy214040-bib-0036){ref-type="ref"}). RBC fatty‐acid status is particularly important for assessing disease risk prediction (Kim et al. [2018](#phy214040-bib-0017){ref-type="ref"}). During exercise, triacylglycerides, an energy reservoir in adipose tissue, are hydrolyzed to free fatty acids, which are then released to the circulation, providing a fuel for working muscles (Mika et al. [2019](#phy214040-bib-0024){ref-type="ref"}). The most consistently observed effect has been an increase in the relative amount of unsaturated, especially monounsaturated, non‐esterified fatty acids in plasma after acute exercise, such as running, cycling, or swimming of moderate intensity for 0.5--2 h per bout (Nikolaidis and Mougios [2004](#phy214040-bib-0025){ref-type="ref"}). These exercise‐related changes in fatty acid metabolism in adipose tissue and circulating blood could contribute to beneficial cardiovascular and metabolic effects of physical activity. We tested the hypothesis that acute, maximal exercise would influence the relationship between RBC and serum fatty acids (Fig. [1](#phy214040-fig-0001){ref-type="fig"}).

![Schematic illustration of the hypothetic influence of short‐term maximal exercise associated with increased vasopressor and shear stress, red blood cell (RBC)‐endothelial interactions, and tissue hypoxia facilitating release of oxygen from RBCs on relative EPA+DHA content in RBC, i.e. omega‐3‐ quotient, which is the percentage of EPA+DHA in red cell fatty acid lipids.](PHY2-7-e14040-g001){#phy214040-fig-0001}

Methods {#phy214040-sec-0002}
=======

The Charité University Medicine institutional review board on the use of humans in research approved the study and written informed consent was obtained. The study was duly registered: ClinicalTrials.gov Identifier: NCT03121885, <https://clinicaltrials.gov/ct2/show/NCT03121885>. Recruitment was primarily *via* person‐to‐person interview. Prior to participation in the study, six healthy volunteers (five male and one female) signed informed consent forms which outlined the procedures to be taken and the possible risks involved. The age of the subjects was 38 ± 15 years. The body mass index of the individuals was 27.9 ± 6.6 kg/m^2^. All subjects were non‐trained. They were not taking medications. Following a routine physical examination at baseline levels, each subject underwent a maximal treadmill Bruce test, which is recommended by guidelines for ergometry of the German Society of Cardiology (Bruce et al. [1973](#phy214040-bib-0004){ref-type="ref"}; Trappe and Lollgen [2000](#phy214040-bib-0037){ref-type="ref"}). The test was preceded by 2 × 3 min warm up periods (stages 1 and 2 of the Bruce protocol) during which treadmill speed was maintained at a constant speed of 2.7 km/h and at zero or 5% grade. Treadmill speed and grade were then increased at three min intervals to a maximum of 20% grade at 8.8 km/h. Workload was assessed in metabolic equivalents (METs) from 5--18 METS. The test was terminated when the subjects informed the investigator that they could no longer proceed.

Heart rates were monitored continuously by heart‐rate monitor worn around the subject\'s torso (Polar T31, Polar Electro, Kempele, Finland) throughout the tests. Arterial pressure was measured in each subject while sitting prior to the exercise test (−10 min), after termination of the test (exhaustion), and 10 min recovery after the end of the running test *via* a sphygmomanometer (Critikon, Inc., Johnson & Johnson, New Jersey), which comprised an inflatable (Riva‐Rocci) cuff placed around the upper arm. Venous blood was collected from a catheter placed in a contralateral forearm vein (i.e. the antecubital vein) of each subject in the sitting position prior to the exercise test (−10 min), after termination of the test (exhaustion), and 10 min recovery after the end of the running test (Fig. [2](#phy214040-fig-0002){ref-type="fig"}). An additional blood sample was collected in each subject during running when the heart rate reached 150 beats per minute. We did not measure blood pressure at this time point (HF 150) because valid blood pressure measurements could not be obtained during running using the above sphygmomanometer. All samples were analyzed for RBC total fatty acids status and plasma free fatty acids. RBC free fatty acid status was determined at rest and at maximal workload. RBCs were separated from EDTA blood by centrifugation and total fatty acids in RBCs or plasma were determined by liquid chromatography mass (HPLC‐MS) spectrometry described in (Fischer et al. [2014](#phy214040-bib-0011){ref-type="ref"}). Serum lactate was determined in blood samples obtained from ear lobe at rest and at maximal workload.

![Schematic illustration of the experimental protocol used. HF, heart rate; BP, blood pressure; RBC, red blood cell; FFA, free fatty acid; FA, fatty acid; FAomics; plasma fatty acid lipidomics. METs, metabolic equivalents of task.](PHY2-7-e14040-g002){#phy214040-fig-0002}

We performed sample size calculation for a difference in means in omega‐3 quotients. We found that our study would require a sample size of 5 (number of pairs) to achieve a power of 80% and a level of significance of 5% (two sided), for detecting a mean of the differences of 0.021 (Harris et al. [2017](#phy214040-bib-0014){ref-type="ref"}) between pairs, assuming the standard deviation of the differences to be 0.88 (Fischer et al. [2014](#phy214040-bib-0011){ref-type="ref"}). Thus, in our sample size calculation, statistical significance and clinical significance both were taken into account.

Descriptive statistics were calculated and variables were examined for meeting assumptions of normal distribution without skewness and kurtosis. In order to determine statistical significance between the trials at the various time intervals, one‐way repeated measures analysis of variance (ANOVA) was conducted and the 0.05 level of significance (*P*) was chosen. The analysis included Mauchly\'s test of sphericity followed by applying the test of within subjects' effects with Greenhouse--Geisser correction to ensure sphericity assumption. When significant differences were found, Tukey\'s honestly‐significant‐difference post‐hoc test was used for pairwise comparisons. Planned hypotheses (one‐tailed or two‐tailed paired *t*‐tests as appropriate) were tested to follow up the initial ANOVA findings. All data are presented as mean ± SD. All statistical analyses were performed using SPSS Statistics software (IBM Corporation, Armonk, NY) or All‐Therapy statistics beta (AICBT Ltd, Vancouver, Canada).

Results {#phy214040-sec-0003}
=======

The hemodynamic and lactate values (Table [1](#phy214040-tbl-0001){ref-type="table"}) confirmed maximal exertion. The values include measurements prior to the exercise test (−10 min, rest), after termination of the test (exhaustion), and 10 min after the end of the running test (recovery period). An additional blood sample was collected in each subject during running when the heart rate reached 150 beats per minute. Exercise induced an increase in both heart rate and systolic blood pressure, which normalized to baseline (resting) levels in the recovery period. All individuals terminated exercise at a maximal workload of 13.50 ± 1.97 METs (Bruce stages 6.33 ± 0.82). Our ANOVA analysis showed that there were differences between heart rate and systolic blood pressure at the different time points: rest (baseline), exhaustion and recovery (Table [1](#phy214040-tbl-0001){ref-type="table"}). At this maximal workload, heart rate, systolic and diastolic blood pressure increased from 71 (baseline) to 185 beats per min from 135 to 190 mmHg and from 81 to 91 mmHg respectively (*P *\<* *0.0001 each, Tukey\'s honestly‐significant‐difference post‐hoc tests, Table [1](#phy214040-tbl-0001){ref-type="table"}). Lactate levels were determined at rest and exhaustion. Lactate levels increased from 1.38 ± 0.30 mmol/L to 9.49 ± 2.10 mmol/L (*P *\<* *0.0001, *t*‐test, Table [1](#phy214040-tbl-0001){ref-type="table"}).

###### 

Effects of exercise on hemodynamics and lactate (means ± SD, *n* = 6)

  Parameter                                  Time point 1 (rest)   Time point 2 (HF 150)   Time point 3 (exhaustion)   Time point 4 (recovery)   Mauchly\'s test, *P* value   Greenhouse--Geisser, *P* value   *t*‐Test, *P* value
  ------------------------------------------ --------------------- ----------------------- --------------------------- ------------------------- ---------------------------- -------------------------------- ---------------------
  Heart rate (beats per min)                 71 ± 10               150                     185 ± 6                     94 ± 11                   \<0.001                      \<0.001                          
  Systolic arterial blood pressure (mm Hg)   135.3 ± 9.1           n.d.                    190.3 ± 16.6                127.5 ± 13.1              \<0.001                      \<0.001                          
  Diastolic arterial blood pressure          81.2 ± 14.4           n.d.                    90.7 ± 16.4                 76.3 ± 10.2               0.065                        0.097                            
  Lactate (mmol/L)                           1.38 ± 0.30           n.d.                    9.49 ± 2.10                 n.d.                                                                                    \<0.001
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Since the impact of acute exercise on individual RBC fatty acids is unknown, we used an explorative statistical approach on measured fatty acid profiles, ranging from C12:0 to C22:6 *n*−3 fatty acids (Table [2](#phy214040-tbl-0002){ref-type="table"}), at the different time points: rest (baseline), the time when heart rate reached 150 beats per min, exhaustion and recovery. Our ANOVA analysis showed that there were no differences between the individual RBC fatty acids of all four groups. Our ANOVA analysis also showed that there were also no differences between omega‐3 quotients of all four groups (Table [3](#phy214040-tbl-0003){ref-type="table"}). The RBC omega‐3 quotients at rest and exhaustion were 0.067and 0.063 respectively (*n* = 6, *P *=* *0.148, *t*‐test). The data indicate that the short‐term maximal exercise is insufficient to alter RBC fatty acid status repeatedly measured during maximal exercise and post exercise periods in healthy individuals, including omega‐3 quotients.

###### 

Lipidomics of RBCs in response to exercise (*n* = 6)

  Fatty acid (*μ*g/g)   Time point 1 (rest)   Time point 2 (HF 150)   Time point 3 (exhaustion)   Time point 4 (recovery)   Mauchly\'s test, *P* value   Greenhouse--Geisser, *P* value
  --------------------- --------------------- ----------------------- --------------------------- ------------------------- ---------------------------- --------------------------------
  C12:0                 1.033 ± 1.677         2.060 ± 2.505           1.638 ± 1.837               0.102 ± 0.250             0.411                        0.296
  C14:0                 16.296 ± 12.774       16.147 ± 2.943          23.435 ± 10.156             14.890 ± 8.277            0.234                        0.271
  C14:1                 0.965 ± 0.230         1.048 ± 0.122           1.278 ± 0.448               1.176 ± 0.413             0.079                        0.201
  C16:0                 551.129 ± 158.224     630.805 ± 160.504       601.531 ± 117.900           526.699 ± 101.248         0.512                        0.355
  C16:1                 16.427 ± 6.420        17.171 ± 2.651          21.676 ± 5.304              17.686 ± 5.453            0.622                        0.248
  C18:0                 349.925 ± 102.151     441.744 ± 156.675       379.324 ± 108.094           326.366 ± 79,891          0.258                        0.202
  C18:1 cis             369.359 ± 109.595     372.508 ± 83.028        386.719 ± 49.709            352.496 ± 70.850          0.784                        0.660
  C18:1 trans           11.990 ± 3.208        13.388 ± 3.860          14,371 ± 38042              12,703 ± 28,339           0.110                        0.444
  C18:2                 378,376 ± 1172,868    382.639 ± 72.9316       420.356 ± 52.0496           371.114 ± 82.9781         0.940                        0.462
  C18:3 *n*−3           8.298 ± 2.8805        8.663 ± 2.2216          10.110 ± 2.5471             8.355 ± 1.9315            0.541                        0.138
  C18:3 *n*−6           3.436 ± 1.1632        3.693 ± 1.009           4.287 ± 1.090               3.521 ± 0.630             0.981                        0.145
  C20:1                 12.580 ± 4.273        11.799 ± 2.585          12.157 ± 1.821              10.424 ± 2.448            0.620                        0.295
  C20:3                 73.136 ± 32.1532      65.684 ± 23.583         68.295 ± 21.397             61.948 ± 24.819           0.193                        0.264
  C20:4 *n*−3           2.538 ± 1.449         2.355 ± 1.189           2.561 ± 1.185               2.213 ± 1.160             0.442                        0.262
  C20:4 *n*−6           442.260 ± 116.511     465.333 ± 85.263        459.271 ± 56.357            431.627 ± 87.459          0.149                        0.629
  C20:5 *n*−3 (EPA)     21.916 ± 5.707        23.876 ± 5.821          24.717 ± 3.954              21.794 ± 3.076            0.432                        0.391
  C22:1                 0.810 ± 0.329         0.873 ± 0.282           0.776 ± 0.178               1.307 ± 1.033             0.001                        0.345
  C22:5 *n*−3           29.426 ± 5.518        29.755 ± 3.613          30.117 ± 4.364              27.642 ± 3.240            0.288                        0.597
  C22:5 *n*−6           7.454 ± 2.019         7.277 ± 1.107           7.362 ± 1.287               6.858 ± 1.664             0.398                        0.566
  C22:6 *n*−3 (DHA)     145.677 ± 57.864      137.331 ± 42.755        138.461 ± 34.927            129.536 ± 48.290          0.631                        0.329
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###### 

Omega‐3 quotient of RBCs in response to exercise (means ± SD, *n* = 6)

  Fatty acid (*μ*g/g)                                             Time point 1 (rest)   Time point 2 (HF 150)   Time point 3 (exhaustion)   Time point 4 (recovery)   Mauchly\'s test, *P* value   Greenhouse--Geisser, *P* value
  --------------------------------------------------------------- --------------------- ----------------------- --------------------------- ------------------------- ---------------------------- --------------------------------
  C20:5 *n*−3 (EPA) + C22:6 *n*−3 (DHA)                           167.593 ± 63.295      161.207 ± 46.482        163.179 ± 36.480            151.330 ± 50.757          0.65                         0.42
  Total fatty acids                                               2443.031 ± 693.691    2634.149 ± 535.512      2608.440 ± 343.774          2328.457 ± 445.098        0.65                         0.42
  \[C20:5 *n*−3 (EPA) + C22:6 *n*−3 (DHA)\] / Total fatty acids   0.0670 ± 0.0087       0.0610 ± 0.0119         0.0631 ± 0.0129             0.0641 ± 0.0135           0.77                         0.09
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High levels of oleic acid (OA, C18:1 cis), palmitic acid (C16:0), palmitoleic acid (C16:1), and alpha‐linolenic acid (C18:3 *n*−3) in RBCs have been found to associate with all‐cause and cardiovascular mortality (Delgado et al. [2017](#phy214040-bib-0008){ref-type="ref"}) or sudden cardiac death (Lemaitre et al. [2009](#phy214040-bib-0020){ref-type="ref"}, [2010](#phy214040-bib-0021){ref-type="ref"}). Our study revealed no change in levels of fatty acids C16.0, C16:1, C18:1, and C18:3 *n*−3 in RBCs at maximal exercise (for all *P *\>* *0.05, *t*‐tests).

We next focused on lauric acid (C12:0), which accumulates in blood under exhaustive exercise or in ischemia (Di Paola and Lorusso [2006](#phy214040-bib-0009){ref-type="ref"}) and is an "exchangeable" or "reversibly‐bound" free fatty acid in RBCs (Spector et al. [1972](#phy214040-bib-0035){ref-type="ref"}) belonging to medium‐chain fatty acids preferentially oxidized in mitochondria in comparison with long‐chain fatty acids (Di Paola and Lorusso [2006](#phy214040-bib-0009){ref-type="ref"}). We therefore hypothesized that RBC lauric acid levels at maximal exercise will decrease in the recovery period. Our results show that RBC lauric acids at exhaustion decreased from 1.638 ± 1.837 to 0.102 ± 0.250 *μ*g/g in the recovery period (*n* = 6, *P *=* *0.035, *t*‐test). This effect was associated with a reduction of heart rate from 185 ± 6 to 94 ± 11 beats per minute (*P *\<* *0.001, Tukey\'s honestly‐significant‐difference post‐hoc test). It was also associated with a decrease of systolic and diastolic blood pressures from 190.3 ± 16.6 to 127.5 ± 13.1 mmHg and from 90.7 ± 16.4 to 76.3 ± 10.2 mmHg, respectively (*P *\<* *0.001 each, Tukey\'s honestly‐significant‐difference post‐hoc tests), which indicates possible involvement of this fatty acid in hemodynamic and metabolic recovery after short‐term maximal exercise.

To provide insights into possible mechanisms underlying effects of exhaustive exercise on individual RBC fatty acids status, we measured circulating plasma free fatty acids (Table [4](#phy214040-tbl-0004){ref-type="table"}). The results show that plasma levels of the free fatty acids C16:0, C16:1, C18:0, C18:1 cis, and C18:2 are relatively high, whereas levels of C12:0, C14:1, C18:3 *n*−6, C20:4 *n*−3, and C22:1 are relatively low. Besides lauric acid (C12:0), none of the circulating free fatty acids did change during exercise and post exercise. We also measured free fatty acids in RBCs (Table [5](#phy214040-tbl-0005){ref-type="table"}). The results show that free levels of fatty acids in RBCs are very low, i.e. \~1--2% of the respective individual total RBC fatty acids. None of the free fatty acids in RBCs did change during exercise (Table [6](#phy214040-tbl-0006){ref-type="table"}). Post exercise circulating plasma level of lauric acid (10.623 ± 11.010 *μ*g/mL) did not differ from circulating levels measured at exhaustion (9.542 ± 10.393 *μ*g/mL, *n* = 6, *P *=* *0.081, *t*‐test).

###### 

Circulating plasma free fatty acids in response to exhaustive exercise (*n* = 6).

  Free fatty acid (*μ*g/mL)   Time point 1 (rest)   Time point 2 (HF 150)   Time point 3 (exhaustion)   Time point 4 (recovery)   Mauchly\'s test, *P* value   Greenhouse--Geisser, *P* value
  --------------------------- --------------------- ----------------------- --------------------------- ------------------------- ---------------------------- --------------------------------
  C12:0                       8.823 ± 9.831         9.168 ± 8.978           9.542 ± 10.393              10.623 ± 11.010           0.316                        0.413
  C14:0                       44.312 ± 10.303       47.071 ± 14.788         49.479 ± 8.381              51.962 ± 13.056           0.154                        0.397
  C14:1                       2.621 ± 0.964         2.702 ± 1.171           2.515 ± 0.575               3.006 ± 1.039             0.270                        0.463
  C16:0                       331.130 ± 41.900      341.226 ± 25.159        347.013 ± 47.183            373.464 ± 42.320          0.687                        0.182
  C16:1                       40.836 ± 10.314       41.121 ± 6.758          39.598 ± 10.293             42.831 ± 10.876           0.623                        0.676
  C18:0                       150.108 ± 23.790      156.811 ± 11.718        157.947 ± 25.934            171.468 ± 22.982          0.818                        0.160
  C18:1 cis                   283.376 ± 44.731      284.895 ± 25.185        282.537 ± 50.712            306.409 ± 39.356          0.634                        0.360
  C18:1 trans                 21.296 ± 9.985        21.123 ± 6.187          22.490 ± 9.685              24.338 ± 8.694            0.177                        0.447
  C18:2                       328.375 ± 59.582      343.606 ± 22.969        333.085 ± 68.081            366.570 ± 46.221          0.588                        0.415
  C18:3 *n*−3                 10.732 ± 2.374        11.089 ± 3.406          10.636 ± 3.306              11.823 ± 2.722            0.440                        0.522
  C18:3 *n*−6                 5.223 ± 2.052         5.201 ± 1.484           4.922 ± 1.967               5.263 ± 1.451             0.242                        0.767
  C20:1                       10.330 ± 2.172        10.007 ± 2.427          8.119 ± 4.589               10.717 ± 2.580            0.229                        0.227
  C20:3                       50.696 ± 25.737       52.777 ± 28.062         51.191 ± 32.891             55.044 ± 33.320           0.004                        0.617
  C20:4 *n*−3                 2.370 ± 1.219         2.571 ± 1.242           2.583 ± 1.561               2.674 ± 1.441             0.158                        0.338
  C20:4 *n*−6                 139.153 ± 28.757      147.097 ± 18.035        139.433 ± 33.707            148.975 ± 24.443          0.192                        0.617
  C20:5 *n*−3 (EPA)           15.563 ± 7.039        16.761 ± 8.005          15.812 ± 8.577              16.580 ± 7.211            0.025                        0.644
  C22:1                       0.609 ± 0.201         0.583 ± 0.146           0.612 ± 0.286               0.660 ± 0.139             0.112                        0.637
  C22:5 *n*−3                 6.968 ± 2.003         7.380 ± 1.419           6.786 ± 2.194               7.303 ± 1.606             0.011                        0.641
  C22:5 *n*−6                 2.353 ± 0.613         2.476 ± 0.436           2.307 ± 0.880               2.533 ± 0.784             0.079                        0.618
  C22:6 *n*−3 (DHA)           43.766 ± 18.081       47.528 ± 18.181         46.919 ± 23.502             48.283 ± 21.276           0.059                        0.493
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###### 

Free fatty acids compared to total fatty acids in RBCs at rest (Time point 1; *n* = 6)

  Fatty acid (*μ*g/g)   Free fatty acids in RBCs   Total fatty acids in RBCs   Percentage of free fatty acids (%)
  --------------------- -------------------------- --------------------------- ------------------------------------
  C12:0                 0.135 ± 0.043              1.033 ± 1.677               13.1
  C14:0                 0.505 ± 0.254              16.296 ± 12.774             1.99
  C14:1                 0.027 ± 0.014              0.965 ± 0.230               2.8
  C16:0                 3.020 ± 0.221              551.129 ± 158.224           0.5
  C16:1                 0.232 ± 0.154              16.427 ± 6.420              1.4
  C18:0                 7.420 ± 1.697              349.925 ± 102.151           2.1
  C18:1 cis             1.615 ± 0.662              369.359 ± 109.595           0.4
  C18:1 trans           0.141 ± 0.083              11.990 ± 3.208              1.2
  C18:2                 0.508 ± 0.291              378,376 ± 1,172,868         1.3
  C18:3 *n*−3           0.150 ± 0.149              8.298 ± 2.8805              1.8
  C18:3 *n*−6           0.018 ± 0.012              3.436 ± 1.1632              0.5
  C20:1                 0.055 ± 0.048              12.580 ± 4.273              0.4
  C20:3 *n*−6           0.025 ± 0.018              73.136 ± 32.1532            3.4
  C20:4 *n*−6           0.278 ± 0.098              442.260 ± 116.511           6.2
  C20:5 *n*−3 (EPA)     0.037 ± 0.005              21.916 ± 5.707              1.3
  C22:1 *n*−9           0.010 ± 0.011              0.810 ± 0.329               1.2
  C22:5 *n*−3           0.673 ± 0.542              29.426 ± 5.518              2.3
  C22:5 *n*−6           0.298 ± 0.330              7.454 ± 2.019               3.9
  C22:6 *n*−3 (DHA)     0.085 ± 0.110              145.677 ± 57.864            5.8
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###### 

Free fatty acids in RBCs in response to exercise (*n* = 6)

  Fatty acid (*μ*g/g)   Time point 1 (rest)   Time point 3 (exhaustion)   t‐test, *P* value
  --------------------- --------------------- --------------------------- -------------------
  C12:0                 0.135 ± 0.043         0.127 ± 0.049               0.76
  C14:0                 0.505 ± 0.254         0.405 ± 0.108               0.39
  C14:1                 0.027 ± 0.014         0.022 ± 0.012               0.51
  C16:0                 3.020 ± 0.221         2.945 ± 0.275               0.614
  C16:1                 0.232 ± 0.154         0.135 ± 0.014               0.16
  C18:0                 7.420 ± 1.697         7.658 ± 1.929               0.82
  C18:1 cis             1.615 ± 0.662         1.297 ± 0.328               0.32
  C18:1 trans           0.141 ± 0.083         0.080 ± 0.028               0.11
  C18:2                 0.508 ± 0.291         0.363 ± 0.080               0.27
  C18:3 *n*−3           0.150 ± 0.149         0.087 ± 0.041               0.34
  C18:3 *n*−6           0.018 ± 0.012         0.013 ± 0.005               0.36
  C20:1                 0.055 ± 0.048         0.035 ± 0.014               0.35
  C20:2 *n*−6           0.023 ± 0.023         0.017 ± 0.008               0.52
  C20:3 *n*−6           0.025 ± 0.018         0.017 ± 0.005               0.29
  C20:4 *n*−6           0.278 ± 0.098         0.225 ± 0.033               0.23
  C20:5 *n*−3 (EPA)     0.037 ± 0.005         0.030 ± 0.006               0.07
  C22:1 *n*−9           0.010 ± 0.011         0.007 ± 0.005               0.51
  C22:5 *n*−3           0.673 ± 0.542         0.432 ± 0.109               0.29
  C22:5 *n*−6           0.298 ± 0.330         0.160 ± 0.039               0.33
  C22:6 *n*−3 (DHA)     0.085 ± 0.110         0.043 ± 0.012               0.38
  C24:1 *n*−9           0.127 ± 0.134         0.098 ± 0.053               0.64
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Discussion {#phy214040-sec-0004}
==========

To our knowledge, this study is the first to assess the impact of acute exercise on individual RBC fatty acids. RBC fatty acid profiling was performed on venous blood taken form healthy subjects undergoing maximal treadmill exercise testing using the standard Bruce protocol, which is used in clinical routine as cardiac stress test to induce strong and robust increases in heart rate and blood pressure (Bruce et al. [1973](#phy214040-bib-0004){ref-type="ref"}; Trappe and Lollgen [2000](#phy214040-bib-0037){ref-type="ref"}). Although we did not confirm our hypothesis that RBC fatty acids, including the omega‐3 quotient, vary during exercise and/or post‐exercise (with exception of RBC lauric acid), we observed significant increases in heart rate, blood pressure and lactate in the volunteers at maximal exercise, which occurred at 13.5 METs. Furthermore, the omega‐3 quotient did also not vary during maximal exercise in healthy volunteers. Finally, short‐term exhaustive exercise did not induce increased mobilization of individual free fatty acids into plasma or greater rate of oxidation of the free fatty acids removed from the circulating blood during exercise.

Omega‐3 fatty acids {#phy214040-sec-0005}
-------------------

The clinical impact of the omega‐3 quotient is well‐established. Omega‐3 index is associated with increased insulin sensitivity and more favorable metabolic profile in middle‐aged overweight men (Albert et al. [2014](#phy214040-bib-0001){ref-type="ref"}) and obese children (Burrows et al. [2011](#phy214040-bib-0006){ref-type="ref"}). A higher omega‐3 index is associated with older age, increasing body mass index, and a history of smoking and fish oil intake in patients with peripheral artery disease (Nosova et al. [2014](#phy214040-bib-0026){ref-type="ref"}). RBC *n*−6 fatty acids have been found to be positively associated, and RBC *n*−3 fatty acids are inversely associated with body weight gain (Wang et al. [2016](#phy214040-bib-0038){ref-type="ref"}). Interestingly, we did not detect changes in alpha‐linolenic acid, which is inversely related to development of adiposity, at least in school‐age children (Perng et al. [2015](#phy214040-bib-0028){ref-type="ref"}). Dietary omega‐3 fatty acids modulate the eicosanoid profile in man primarily *via* the CYP‐epoxygenase pathway, which could function as mediators of the vasodilatory and cardioprotective effects of omega‐3 fatty acids (Fischer et al. [2014](#phy214040-bib-0011){ref-type="ref"}). Recent results demonstrate that CYP enzymes efficiently convert EPA and DHA to novel epoxy and hydroxy metabolites that could mediate some of the beneficial cardiovascular effects of dietary omega‐3 fatty acids (Arnold et al. [2010](#phy214040-bib-0002){ref-type="ref"}). In recent randomized, double‐blind, placebo‐controlled trials, dietary *n*−3 fatty acid supplementation (3--6 g daily) mitigated the course of coronary atherosclerosis in humans (von Schacky et al. [1999](#phy214040-bib-0032){ref-type="ref"}), but had (1 g daily) no cardiovascular benefit in initially healthy adults and in patients with diabetes mellitus (Group et al. [2018](#phy214040-bib-0013){ref-type="ref"}; Manson et al. [2018](#phy214040-bib-0022){ref-type="ref"}). Nevertheless, recent data show that dietary EPA (4 g daily, REDUCE‐IT trial) is effective for prevention of major coronary events in hypercholesterolaemic patients (Yokoyama et al. [2007](#phy214040-bib-0040){ref-type="ref"}) and cardiovascular events in patients with established cardiovascular disease or with diabetes and other risk factors (Bhatt et al. [2018](#phy214040-bib-0003){ref-type="ref"}). Our results support the concept that the omega‐3‐ quotient is strongly affected by diet, e.g. DHA/EPA‐rish fish oil, but not acute maximal exercise.

Omega‐9 fatty acids {#phy214040-sec-0006}
-------------------

High levels of omega‐9 monounsaturated fatty acids, oleic acid (OA, C18:1 cis), gondoic acid (GA, C20:1), and nervonic acid (NA, C24:1) in RBCs showed increased all‐cause and cardiovascular mortality in the Ludwigshafen Risk and Cardiovascular Health Study (Delgado et al. [2017](#phy214040-bib-0008){ref-type="ref"}). High levels of palmitic acid (C16:0) palmitoleic acid (C16:1), oleic acid (C18:1), and alpha‐linolenic acid (C18:3 *n*−3) were also associated with higher risk of sudden cardiac death (Lemaitre et al. [2009](#phy214040-bib-0020){ref-type="ref"}, [2010](#phy214040-bib-0021){ref-type="ref"}). Our study revealed a tendency towards elevated levels of the fatty acids C16.0, C16:1, C18:1, and C18:3 *n*−3 in RBC at exhaustion, but the effects were not statistically significant. Future studies are warranted to explore biologic and prognostic properties of omega‐9 fatty acids in long‐term effects on cardiovascular disease.

Lauric acid {#phy214040-sec-0007}
-----------

Lauric acid (C12:0) is the primary fatty acid found in coconut oil. High‐coconut Nourish and high‐virgin coconut oil diets improve cardiovascular and liver complications in obesity in rats (Panchal et al. [2017](#phy214040-bib-0027){ref-type="ref"}). RBCs have at least two classes of fatty acid binding sites for laurate and possibly other medium‐chain fatty acids (Spector et al. [1972](#phy214040-bib-0035){ref-type="ref"}). The stronger class has approximately 1.2 × 10^5^ sites/cell and an association constant for laurate of 1.8 × 10^6^ mol/L. These strong sites probably bind much of the "nonexchangeable" or "irreversibly bound" free fatty acid pool of the cell. The large, weaker class of binding sites contains approximately 8.0 × 10^6^ sites/cell and has an association constant for laurate of 1.3 × 10^4^ mol/L. The fatty acid present at these sites probably represents the "exchangeable" or "reversibly‐bound" free fatty acid pool of the cell (Spector et al. [1972](#phy214040-bib-0035){ref-type="ref"}). The observed post exercise decrease in RBC lauric acid (C12:0) could contribute to gain access to the lipid energy reserves in skeletal muscle, liver, and heart (Di Paola and Lorusso [2006](#phy214040-bib-0009){ref-type="ref"}; Exercise‐induced [2017](#phy214040-bib-0010){ref-type="ref"}), where medium‐chain fatty acids appear to be preferentially oxidized in mitochondria compared to long‐chain fatty acids. Since circulating C12:0 plasma levels and free C12:0 levels in RBCs were not affected by exercise, the decrease of total RBC lauric acid is possibly caused from its "nonexchangeable" or "irreversibly bound" free fatty acid pool in the red blood cells. The functional importance and downstream effects of lauric acid in metabolic and hemodynamic post exercise recovery remain to be determined.

Exercise protocol considerations {#phy214040-sec-0008}
--------------------------------

The modified Bruce protocol was selected to ensure that all subjects were able to complete a similar highest intensity workload (13.50 ± 1.97 METs) concomitant with robust and significant short‐term increases in heart rate and blood pressure without fatiguing. For consistency, we used also an intermediate workload (10.00 ± 1.90 METs, *P *=* *0.0009, *t*‐test) reaching a heart rate of 150 or more beats per min to ensure that all runners could complete the test with marked increases in heart rate and blood pressure without fatiguing. Our clinical data show that the exercise protocol caused the expected hemodynamic and metabolic changes in the subjects under study.

Limitations {#phy214040-sec-0009}
===========

We obtained venous blood from an arm vein, although the source free and RBC fatty acids, if modified from exercising muscle and its vasculature, suggests that the leg would provide a different measure. However, blood samples were taken from the arm vein because of the great difficulty associated with obtaining blood from a vein in dynamically contracting leg muscles. Therefore, stronger effects may have been present in the venous effluent of the exercising muscle (Giordano et al. [2011](#phy214040-bib-0012){ref-type="ref"}). We studied effects of maximal short‐term exercise, but not endurance exercise, which may also lead to different results. Interestingly, elite athletes have an increased incidence of sudden death and low omega‐3‐quotients (von Schacky et al. [2014](#phy214040-bib-0033){ref-type="ref"}). However, it is unknown whether this deficiency in omega‐3‐quotient results from reduced diet or extreme endurance exercise training.

Conclusions {#phy214040-sec-0010}
===========

Our results suggest that dynamic exercise does not change the levels of RBC *n*−3 fatty acid status in the systemic circulation. Our results are consistent with the idea that the essential fatty acids (*n*−3 and *n*−6) are strongly affected by diet (Fischer et al. [2014](#phy214040-bib-0011){ref-type="ref"}), but not short‐term maximal exercise, whereas changes in RBC lauric acid, which can be synthesized *de novo* and is bound in red blood cells, reflects metabolic processes. More research is needed to determine the contribution of RBC fatty acids to cardiac performance and regulation of coronary and/or skeletal‐muscle blood flow in health and cardiovascular disease.
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